MannKind Corp. Stock
MannKind Corp. Stock
The MannKind Corp. stock is trending slightly upwards today, with an increase of €0.015 (0.370%) compared to yesterday's price.
With 7 Buy predictions and not the single Sell prediction the community is currently very high on MannKind Corp..
With a target price of 6 € there is a positive potential of 46.95% for MannKind Corp. compared to the current price of 4.08 €.
Pros and Cons of MannKind Corp. in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of MannKind Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
MannKind Corp. | 0.370% | 4.665% | -0.049% | 14.691% | 21.157% | 11.314% | 204.929% |
Ardelyx Inc. | 28.120% | 34.723% | 18.969% | 89.624% | 39.758% | 44.250% | - |
Evolus Inc | 10.280% | 12.381% | -5.600% | 60.544% | 30.387% | 60.544% | - |
Salarius Pharmaceuticals Inc. | 11.650% | 7.981% | 17.949% | -67.606% | -17.117% | -98.248% | -99.993% |
Comments
MannKind Co. (NASDAQ: MNKD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $6.50 price target on the stock.
Show more
Ratings data for MNKD provided by MarketBeat
MannKind Co. (NASDAQ: MNKD) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $10.00 price target on the stock.
Show more
Ratings data for MNKD provided by MarketBeat
MannKind Co. (NASDAQ: MNKD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $6.50 price target on the stock.
Show more
Ratings data for MNKD provided by MarketBeat